Arthur H. Amron - 16 Mar 2026 Form 4 Insider Report for NEPHROS INC (NEPH)

Role
Director
Signature
/s/ Christopher Melsha Attorney-in-Fact for Arthur H. Amron pursuant to Power of Attorney filed herewith.
Issuer symbol
NEPH
Transactions as of
16 Mar 2026
Net transactions value
$0
Form type
4
Filing time
18 Mar 2026, 17:23:08 UTC
Previous filing
15 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Amron Arthur H Director C/O NEPHROS, INC., 380 LACKAWANNA PLACE, SOUTH ORANGE /s/ Christopher Melsha Attorney-in-Fact for Arthur H. Amron pursuant to Power of Attorney filed herewith. 18 Mar 2026 0001179697

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEPH Common Stock Award +3,610 +2.8% $0.000000* 134,882 16 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEPH Stock Option (Right to Buy) 7,323 16 Mar 2026 Common Stock 7,323 $2.14 Direct F2
holding NEPH Stock Option (Right to Buy) 7,050 16 Mar 2026 Common Stock 7,050 $1.47 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares issued to reporting person in lieu of cash fees for board service.
F2 This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26.
F3 This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27.